PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Kivitz, Alan
TI  - SC Tocilizumab Reduces RA Disease Activity When Used with DMARDs
DP  - 2012  01
TA  - MD Conference Express
PG  - 18--19
VI  - 12
IP  - 19
4099  - http://mdc.sagepub.com/content/12/19/18.2.short
4100  - http://mdc.sagepub.com/content/12/19/18.2.full
AB  - When used in combination with traditional disease-modifying antirheumatic drugs, response rates were significantly superior with a subcutaneous form of tocilizumab compared with placebo in a 24-week Phase 3 study of patients with moderate to severe rheumatoid arthritis.